Dafna Capital Management Llc Portfolio Stock Holdings
According to the SEC 13F filed on August 14, 2026, Dafna Capital Management Llc disclosed 71 stock positions valued at approximately $524.36M as of quarter-end June 30, 2026. The largest holdings include REVOLUTION MEDICINES INC, SPDR S&P BIOTECH ETF, and COMPASS PATHWAYS PLC.
- Report Period
- June 30, 2026
- No. of Stocks
- 71
- Portfolio Value
- $524.36M
Holdings by Sector
Dafna Capital Management Llc Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| REVOLUTION MEDICINES INC | RVMD | Healthcare | 20.09% | 562,630 | -18,048 | -3.11% | $105,369,346 |
| SPDR S&P BIOTECH ETF | XBI | Other | 5.93% | 196,505 | -122,000 | -38.30% | $31,096,916 |
| COMPASS PATHWAYS PLC | CMPS | Healthcare | 5.43% | 2,011,952 | -406,930 | -16.82% | $28,469,121 |
| STEREOTAXIS INC | STXS | Healthcare | 4.49% | 13,680,554 | - | - | $23,530,553 |
| DENALI THERAPEUTICS INC | DNLI | Healthcare | 3.62% | 739,014 | +420,514 | +132.03% | $19,007,440 |
| IDEAYA BIOSCIENCES INC | IDYA | Healthcare | 3.53% | 497,240 | +20,500 | +4.30% | $18,532,135 |
| ATRICURE INC | ATRC | Healthcare | 3.19% | 597,431 | - | - | $16,716,119 |
| XENON PHARMACEUTICALS INC | XENE | Healthcare | 2.89% | 250,772 | - | - | $15,136,598 |
| CYTOKINETICS INC | CYTK | Healthcare | 2.79% | 171,998 | -45,499 | -20.92% | $14,652,510 |
| ARCUS BIOSCIENCES INC | RCUS | Healthcare | 2.60% | 441,829 | -2,000 | -0.45% | $13,621,588 |
| NEUROCRINE BIOSCIENCES INC | NBIX | Healthcare | 1.86% | 57,769 | -12,846 | -18.19% | $9,736,098 |
| AXOGEN INC | AXGN | Healthcare | 1.84% | 208,960 | -41,000 | -16.40% | $9,651,862 |
| INSULET CORP | PODD | Healthcare | 1.80% | 61,870 | +51,000 | +469.18% | $9,419,708 |
| EDGEWISE THERAPEUTICS INC | EWTX | Healthcare | 1.76% | 226,819 | +114,583 | +102.09% | $9,215,656 |
| BICARA THERAPEUTICS INC | BCAX | Other | 1.61% | 284,955 | -136,778 | -32.43% | $8,460,314 |
| ISHARES NASDAQ BIOTECH INDX | IBB | Other | 1.54% | 42,595 | -19,500 | -31.40% | $8,101,143 |
| SYNDAX PHARMACEUTICALS INC | SNDX | Healthcare | 1.40% | 335,255 | +117,900 | +54.24% | $7,328,674 |
| MAPLIGHT THERAPEUTICS INC | MPLT | Other | 1.17% | 171,006 | - | - | $6,128,855 |
| LARIMAR THERAPEUTICS INC | LRMR | Healthcare | 1.17% | 2,008,164 | -21,000 | -1.03% | $6,124,900 |
| CENTURY THERAPEUTICS INC | IPSC | Healthcare | 1.12% | 2,400,458 | -33,895 | -1.39% | $5,881,122 |
| DEXCOM INC | DXCM | Healthcare | 1.11% | 86,279 | - | - | $5,810,891 |
| IMMUNOVANT INC | IMVT | Healthcare | 1.10% | 149,524 | -1,000 | -0.66% | $5,761,160 |
| INOGEN INC | INGN | Healthcare | 1.04% | 845,179 | - | - | $5,451,405 |
| TANDEM DIABETES CARE INC | TNDM | Healthcare | 1.02% | 355,208 | - | - | $5,360,089 |
| ALKERMES PLC | ALKS | Healthcare | 1.01% | 101,266 | -38,216 | -27.40% | $5,305,832 |
| STOKE THERAPEUTICS INC | STOK | Healthcare | 0.82% | 130,875 | - | - | $4,282,230 |
| ALLOGENE THERAPEUTICS INC | ALLO | Healthcare | 0.79% | 2,000,000 | +629,882 | +45.97% | $4,160,000 |
| BIOCRYST PHARMACEUTICALS INC | BCRX | Healthcare | 0.76% | 400,248 | -30,000 | -6.97% | $4,002,480 |
| LAKEFRONT BIOTHERAPEUTICS NV | GLPG | Healthcare | 0.74% | 130,175 | - | - | $3,902,647 |
| ORTHOPEDIATRICS CORP | KIDS | Healthcare | 0.69% | 189,130 | +93,471 | +97.71% | $3,618,057 |
Showing 30 of 71 holdings in the latest reporting period.